z-logo
open-access-imgOpen Access
Evaluation of the Collateral Activity Of CRISPR/Cas13a-Ribonuclease on the Agilent 2100 Bioanalyzer
Author(s) -
Leonid K. Kurbatov,
Sergey P. Radko,
Svetlana A. Khmeleva,
О.С. Тимошенко,
А.В. Лисица
Publication year - 2022
Publication title -
biomedical chemistry research and methods
Language(s) - English
Resource type - Journals
ISSN - 2618-7531
DOI - 10.18097/bmcrm00169
Subject(s) - ribonuclease , crispr , heterologous , rna , computational biology , recombinant dna , collateral damage , ribosomal rna , chemistry , chromatography , computer science , biology , biochemistry , criminology , sociology , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom